Ppla
Pharmaceutical Literature
Based in NY
🤖
AI Overview
With $630K in lobbying spend across 34 quarterly filings, Ppla is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
$630K
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $19K |
| 2019 | $75K |
| 2020 | $75K |
| 2021 | $75K |
| 2022 | $75K |
| 2023 | $75K |
| 2024 | $75K |
| 2025 | $163K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ppla disclosed contacting in their lobbying filings.
Food & Drug Administration (FDA)
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, MED
Pharmaceutical labeling and patient safety
Pharmaceutical labeling
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.